SCHEMBL4853019

SCHEMBL4853019

COc1ccc(/C=C/C(=O)c2cccc(OCCCN(C)C)c2)c(OC)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.61
ALDH1A1 P00352 4/20 0.61
NPC1 O15118 3/20 0.61
RAB9A P51151 3/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
TNFRSF1A P19438 1/20 0.58
PTPN1 P18031 2/20 0.54
LMNA P02545 2/20 0.54
HPGD P15428 2/20 0.54
KEAP1 Q14145 1/20 0.53
NFE2L2 Q16236 1/20 0.53
CYP1A1 P04798 4/20 0.52
CYP1B1 Q16678 3/20 0.52
BCHE P06276 1/20 0.52
ACHE P22303 1/20 0.52
ABCG2 Q9UNQ0 1/20 0.51
KDM4E B2RXH2 2/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
MAPK1 P28482 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854277 1.00 MAPT (0.61) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4854108 0.95 MAPT (0.63) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4854815 0.95 MAPT (0.63) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4852947 0.92 ABCG2 (0.59) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4857305 0.92 ABCG2 (0.59) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4850077 0.90 KEAP1 (0.65) MAPTALDH1A1NPC1RAB9APTPN1
SCHEMBL4846703 0.90 KEAP1 (0.65) MAPTALDH1A1NPC1RAB9APTPN1
SCHEMBL8154777 0.89 MAPT (0.67) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL7193109 0.89 MAPT (0.67) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL7193105 0.89 MAPT (0.67) MAPTALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed